Common Contracts

SETTLEMENT AGREEMENT

Settlement Agreement • January 8th, 2018 • Connecticut

• Contract Type
  Settlement Agreement
• Filed
  January 8th, 2018
• Jurisdiction
  Connecticut

THIS SETTLEMENT AGREEMENT (the “Settlement Agreement”) is made and entered into on December 22, 2017, by and between Defendants Boehringer Ingelheim Pharma GmbH & Co KG, Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. (“Boehringer”); and Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Barr Pharmaceuticals, Inc. (n/k/a Barr Pharmaceuticals, LLC), Barr Laboratories Inc., Duramed Pharmaceuticals Inc. (n/k/a Teva Women's Health Inc.), and Duramed Pharmaceutical Sales Corp. (n/k/a Teva Sales and Marketing, Inc.) (“Teva”) (collectively “Defendants”); and Indirect End-Payor Purchaser Class Plaintiffs’ (a.k.a. “End Payor Class Plaintiffs”) Lead Counsel acting pursuant to the Court's Order, dated June 16, 2014 (Doc. No. 95), on behalf of Plaintiffs, A.F. of L. – A.G.C. Building Trades Welfare Plan; AFSCME District Council 47 Health and Welfare Fund; AGC-International Union of Operating Engineers Local 701 Health & Welfare Trust Fund;